CRAD001C2X01B

Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.


New York University Medical Center SC-4
New York, NY 10016
855-737-2873

Carl and Dorothy Bennett Cancer Center at Stamford Hospital
34 Shelburne Road
Stamford, CT 06904
203-323-8944

Novartis Investigative Site
Barcelona 08035

Novartis Investigative Site
Milano 20141

Central Indiana Cancer Centers SC
Indianapolis, IN 46227
317-678-2739

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
660 South Euclid Avenue
St. Louis, MO 63110
314-747-7417

Hematology Oncology Services of Arkansas
9101 Kanis Road
Suite 200
Little Rock, AR 72205
501-907-6444

Nebraska Cancer Specialists Onc Dept
Omaha, NE 68154
402-691-6972

Crescent City Research Consortium
Metairie, LA 70006
504-883-2968

Rocky Mountain Cancer Centers - Greenwood Village
Greenwood Village, CO 80111
303-418-7600

Knight Cancer Institute at Oregon Health and Science University
3181 Southwest Sam Jackson Park Road
Corvallis, OR 97331
541-737-9534

Novartis Investigative Site
Milano 20133

Novartis Investigative Site
Arezzo 52100

Novartis Investigative Site
Bangkok 10700

Novartis Investigative Site
Seoul 120-752

Novartis Investigative Site
Seoul 110 744